Everolimus stent shows advantage over paclitaxel
13 January 2010
| by Nicola Garrett
Paclitaxel-eluting stents should no longer be used in everyday clinical practice, say the authors of a study that found better clinical outcomes with everolimus stents....
Want to read complete article? Please Sign in or Register.